MedPath

School-Based Intervention to Enhance Resilience and Stress Coping in Rural Chinese Adolescents

Not Applicable
Recruiting
Conditions
Stress, Emotional
Stress-related Mental Disorders
Registration Number
NCT07115186
Lead Sponsor
Peking University
Brief Summary

This study aims to evaluate the effectiveness of school-based psychological interventions in improving stress resilience and coping skills among adolescents in rural China. The intervention seeks to reduce stress-related mental health symptoms, including depression, anxiety, and post-traumatic stress, measured using validated instruments such as the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder 7-item scale (GAD-7), and the Child PTSD Symptom Scale for DSM-5 (CPSS-5). (See Appendix for full scale descriptions.)

Participants will be recruited from rural middle schools and randomly assigned to either an intervention group or a wait-list control group. The intervention consists of four sessions delivered over one week. Assessments will be conducted at baseline, immediately after the intervention, and again at a 3-month and 6-month follow-ups.

Researchers will use multilevel modeling (MLM) and structural equation modeling (SEM) to examine potential mediators and moderators of intervention effects, including emotion recognition, alexithymia, and coping strategies. indings are expected to provide evidence on the effectiveness and mechanisms of an existing, school-based psychological intervention tailored to the needs of adolescents in underserved rural settings.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
850
Inclusion Criteria
  • Currently enrolled middle school students attending regular school classes
  • Sufficient functional capacity in hearing, speaking, reading, and writing to participate in intervention activities and assessments.
Exclusion Criteria
  • Individuals assessed to be at high risk of suicide, based on screening or clinical judgment
  • Diagnosis of severe mental disorders (e.g., psychotic disorders, severe mood disorders) that would interfere with participation or require more intensive clinical care

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
PTSD for adolescentsbaseline, post treatment (2 weeks after baseline), 3 month after post treatment

The Child PTSD Symptom Scale for DSM-5 (CPSS-5) for adolescents and children (scores from 0 to 4, and total scores vary from 0 to 80). A higher score represents worse PTSD symptoms.

Depressionbaseline, post treatment (2 weeks after baseline), 3 month after post treatment

The 9-item patient health questionnaire (PHQ-9) for adults (score ranges from 0 to 3, and the total score varies from 0 to 27). A higher score indicates worse depression symptoms.

Insomnia Severitybaseline, post treatment (2 weeks after baseline), 3 month after post treatment

The severity of insomnia symptoms will be assessed using the Insomnia Severity Index (ISI). This 7-item self-report measurement evaluates the severity of insomnia symptoms, the level of satisfaction with sleep, interference with daily functioning, noticeability of impairment attributed to sleep problems, and the level of distress caused by sleep disturbance (score from 0 to 4, and total score vary from 0 to 32). Each item is rated on a 5-point scale, providing a comprehensive measure of insomnia severity.

Alexithymiabaseline, post treatment (2 weeks after baseline), 3 month after post treatment

A 22-item Peking alexithymia scale measures thoughts and behaviors that prevent people from feeling or recognizing negative emotions on a 5-point Likert scale (1 to 5, and total scores vary from 22 to 110). A higher score represents more severe alexithymia.

Generalized anxiety disorderbaseline, post treatment (2 weeks after baseline), 3 month after post treatment

The Generalized Anxiety Disorder-7 scale (GAD-7) for adults, adolescents, and children (scored from 0 to 3, and total score from 0 to 21). A higher score represents worse anxiety symptoms.

Emotion awarenessbaseline, post treatment (2 weeks after baseline), 3 month after post treatment

A 30-item Emotion awareness questionnaire measures emotion awareness on a 3-point Likert scale (1 to 3, with total scores ranging from 30 to 90). A higher score indicates better emotion awareness.

Secondary Outcome Measures
NameTimeMethod
Subjective Happiness Scalebaseline, post treatment (2 weeks after baseline), 3 month after post treatment

A 4-item subjective happiness scale measures happiness (score from 1 to 7, and total score vary from 4 to 28). A higher score represents a happier state.

Frustrationbaseline, post treatment (2 weeks after baseline), 3 month after post treatment

The 25-item frustration scale (score from 1 to 5, and total score varies from 24 to 120). A higher score represents less frustration.

Resiliencebaseline, post treatment (2 weeks after baseline), 3 month after post treatment

The Connor-Davidson resilience scale is a 10-item resilience measurement scale that measures resilience on a 5-point Likert scale (scores range from 0 to 4, and the total score varies from 0 to 40). A higher score represents better resilience.

Self-esteembaseline, post treatment (2 weeks after baseline), 3 month after post treatment

A 10-item self-esteem measurement scale, Rosenberg self-esteem scale, measures self-esteem on a 4-point Likert scale (score from 0 to 3, and total score varies from 0 to 30), with higher scores indicating greater self-esteem.

Irritabilitybaseline, post treatment (2 weeks after baseline), 3 month after post treatment

A 17-item irritability measurement scale, the Peking irritability scale, measures impulsive emotions, thoughts, and behaviors on a 5-point Likert scale (score from 1 to 5, and total score varies from 17 to 85). A higher score represents higher irritability.

Cognitive emotion regulationbaseline, post treatment (2 weeks after baseline), 3 month after post treatment

An 18-item cognitive emotion regulation questionnaire measures the ability of emotion regulation on a 5-point Likert scale (1 to 5, and total scores vary from 18 to 90). A higher score represents more emotion regulation.

Game Addiction Scalebaseline, post treatment (2 weeks after baseline), 3 month after post treatment

A 7-item game addiction scale measures game addiction on a 5-point Likert scale (score from 1 to 5, and total score varies from 7 to 35), with higher scores indicating worse game addiction.

Trial Locations

Locations (1)

Biancun middle school

🇨🇳

Hebei, Baoding, China

Biancun middle school
🇨🇳Hebei, Baoding, China
Liang Yachai
Contact
86+ 03125217599

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.